Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Cancer Prediction”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Not applicableEnded earlyNCT01815463
What this trial is testing

Non-Invasive Prediction of Colorectal Neoplasia

Who this might be right for
Colonic PolypsPolyposis ColiColorectal Cancer
Corporal Michael J. Crescenz VA Medical Center 2,282
Not applicableUnknownNCT05685836
What this trial is testing

89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

Who this might be right for
Neurofibromatosis 2
Leiden University Medical Center 15
Not applicableLooking for participantsNCT04622462
What this trial is testing

Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment

Who this might be right for
Oral Neoplasm
Proteocyte Diagnostics Inc. 500
Not applicableUnknownNCT04758455
What this trial is testing

The Use of Immunohistochemical Staining for the Prediction of Wilms Tumour Progression and Recurrence

Who this might be right for
Wilms TumorRelapseDeath
Mansoura University 75
Not applicableLooking for participantsNCT03267459
What this trial is testing

Can Pretreatment MRI be Used to Predict Intra-arterial Chemotherapy Response in Retinoblastoma?

Who this might be right for
Retinoblastoma
Fondation Ophtalmologique Adolphe de Rothschild 60
Not applicableStudy completedNCT06982053
What this trial is testing

[68Ga]Ga-GZP PET for Early Response Prediction in Colorectal Cancer During Neoadjuvant Therapy

Who this might be right for
Colorectal Cancer Control and PreventionColorectal Cancer RecurrentColorectal Cancer Metastatic+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 21
Not applicableNot Yet RecruitingNCT03359304
What this trial is testing

The Neurofibromatosis-associated Tumor Biobank

Who this might be right for
Neurofibromatoses
Ren tingting 300
Not applicableLooking for participantsNCT06564428
What this trial is testing

A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration

Who this might be right for
Ovarian Neoplasms
Peking University Third Hospital 1,000
Not applicableLooking for participantsNCT07039552
What this trial is testing

Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer Probands

Who this might be right for
Hereditary Breast and Ovarian Cancer SyndromeBRCA Mutations
Peking University Third Hospital 10,000
Not applicableLooking for participantsNCT05463796
What this trial is testing

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Who this might be right for
Cancer RiskCancer Predisposition SyndromeHereditary Cancer Prediction+28 more
Dana-Farber Cancer Institute 5,000
Not applicableLooking for participantsNCT06391879
What this trial is testing

Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma

Who this might be right for
VHL SyndromeRenal Cell Carcinoma
Peking University First Hospital 300
Not applicableActive Not RecruitingNCT04759781
What this trial is testing

MElanoma Research Lymph Node Prediction Implementation National_001

Who this might be right for
Melanoma
SkylineDx 1,820
Not applicableNot Yet RecruitingNCT06662708
What this trial is testing

Artificial Intelligence Models for Precision Prediction and Treatment of Prostate Cancer

Who this might be right for
Prostate CancerProstate Intraductal CarcinomaProstate Cancer Aggressiveness+2 more
Shao Pengfei 200